Key Points Interested in Tarsus Pharmaceuticals, Inc.? Here are five stocks we like better. Tarsus Pharmaceuticals closed its ...

The demise of a copay assistance program for people who receive eye injections for retinal diseases has disproportionately raised out-of-pocket costs for lower-income patients and those on fixed ...

If you have wet age-related macular degeneration (wet AMD) or another disease of the retina, your doctor may recommend treatment with an anti-VEGF drug. VEGF, or vascular endothelial growth factor, is ...

A new study suggests that eye drops developed by Columbia University researchers could be a more effective–and comfortable–therapy for a common eye disease currently treated with injections into the ...

A funding shortfall for a key copay assistance program to help make eye injections more affordable for low-income patients has caused widespread disruption in treatment, researchers have found. The ...

Could a microscopic "geode" of medicine be the future of eye care? A new study shows how crystalline drug delivery could ...

People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

A new study in mice suggests experimental eye drops may be more effective than injections for treatment of retinal vein occlusion, a major cause of blindness. A new study suggests that eye drops ...